Example: Heart Attack

Search clinical trials for: Rivastigmine

Total 92 results

NCT04226248

Recruiting

CHIEF PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

Conditions: Parkinson Disease
NCT04189666

Completed

Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium

Conditions: Delirium
NCT03959124

Recruiting

Deep Brain Stimulation for Alzheimer's Disease

Conditions: Alzheimer Disease; Dementia, Alzheimer Type; Deep Brain Stimulation
NCT03957174

Completed

Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans

Conditions: Healthy
NCT03915626

Recruiting

Effect of Heat on Rivastigmine TDS Products

Conditions: Bioavailability
NCT03840837

Recruiting

Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease

Conditions: Parkinson Disease
NCT03659435

Completed

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

Conditions: Bioequivalence
NCT03573050

Completed

Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase

Conditions: Bioequivalence
NCT03565809

Active, not recruiting

Quality of the Management of Diabetes in Elderly People With Dementia in France

Conditions: Alzheimer Disease
NCT03454646

Not yet recruiting

Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)

Conditions: Alzheimer Disease; Cholinesterase Inhibitors
NCT02989402

Recruiting

A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.

Conditions: Alzheimer's Disease
NCT02839642

Unknown status

Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy

Conditions: Progressive Supranuclear Palsy (PSP)
NCT02703636

Completed

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Conditions: Mild to Moderate Alzheimer's Disease
NCT02670161

Enrolling by invitation

Quality Improvement and Practice Based Research in Neurology Using the EMR

Conditions: Brain Tumors; Epilepsy; Migraine; Mild Cognitive Impairment; Concussion; Multiple Sclerosis; Neuropathy; Parkinson's; Restless Legs Syndrome; Stroke
NCT02623764

Unknown status

EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors

Conditions: Alzheimer´s Disease
NCT02444637

Unknown status

Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD

Conditions: Alzheimer Disease; CVA (Cerebrovascular Accident)
NCT02413554

Completed

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.

Conditions: Delirium
NCT02374567

Terminated

Pharmacovigilance in Gerontopsychiatric Patients

Conditions: Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety Disorders
NCT02187276

Completed

The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia

Conditions: Alzheimer Disease, Late Onset
NCT02063269

Unknown status

Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles

Conditions: Alzheimer's Disease
NCT02035982

Completed

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease

Conditions: Alzheimer's Disease; Dementia
NCT01951118

Completed

Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

Conditions: Alzheimer Disease; Mild Cognitive Impairment; Delirium, Dementia, Amnestic, Cognitive Disorders
NCT01948791

Completed

16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients

Conditions: Alzheimer's Disease
NCT01944436

Completed

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease

Conditions: Lewy Body Disease
NCT01856738

Terminated

Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease

Conditions: Parkinson's Disease
NCT01852110

Terminated

Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)

Conditions: Alzheimer's Disease
NCT01696591

Unknown status

The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD

Conditions: Alzheimer Disease; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Delirium, Dementia, Amnestic, Cognitive Disorders; Mental Disorders
NCT01696123

Completed

Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine

Conditions: Alzheimer Disease
NCT01677754

Completed

A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

Conditions: Alzheimer's Disease
NCT01670526

Completed

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI

Conditions: Traumatic Brain Injury; Cognitive Impairment
NCT01614886

Completed

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

Conditions: Alzheimer's Disease
NCT01602198

Terminated

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

Conditions: Mild Cognitive Disorder; Mild Cognitive Impairment
NCT01585272

Completed

Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia

Conditions: Alzheimer's Dementia
NCT01529619

Completed

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Conditions: Alzheimer's Disease
NCT01519271

Completed

Mild Cognitive Impairment in Parkinson's Disease

Conditions: Parkinson's Disease; Mild Cognitive Impairment
NCT01487317

Completed

Rivastigmine in the Management of Delirium

Conditions: Delirium
NCT01399125

Completed

A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease

Conditions: Alzheimer's Disease
NCT01380288

Completed

Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine

Conditions: Alzheimer's Disease
NCT01362686

Terminated

Comparative Research of Alzheimer's Disease Drugs

Conditions: Dementia; Alzheimer's Disease
NCT01348282

Completed

Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study

Conditions: Neurocognitive Disturbance; HIV Infection
NCT01340885

Completed

Cognitive Decline in Non-demented PD

Conditions: Parkinson's Disease
NCT01312363

Completed

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients

Conditions: Alzheimer's Disease
NCT01183806

Completed

Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients

Conditions: Alzheimer Disease
NCT01146041

Completed

Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions

Conditions: Healthy
NCT01146067

Completed

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

Conditions: Healthy
NCT01084135

Completed

Rivastigmine Study in Adolescents With Down Syndrome

Conditions: Down Syndrome
NCT01073319

Completed

Rivastigmine as a Treatment for Methamphetamine Dependence

Conditions: Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
NCT01047579

Completed

A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease

Conditions: Alzheimer's Disease
NCT01030692

Completed

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence

Conditions: Cocaine Dependence; Cocaine Addiction; Cocaine Abuse; Substance Abuse
NCT01025466

Completed

Exelon Patch and Combination With Memantine Comparative Trial

Conditions: Alzheimer's Disease

Search clinical trials for: Rivastigmine

Recent CRA jobs

Clinical Manager - Home-Based - West/Midwest

Scientist - Large Molecule HPLC ( SEC , IEX , RP )

Sr. Lab Tech/Scient Aff Spec

Sr Project Manager - Peri and Post Approval - Interventional Hematolgy / Oncology Team

Sr Project Manager - Gene Therapy / Rare Diseases

Manager Commercial Dev

CRA - Study Start Up

Associate Scientist / Scientist - Instrument Technician , GMP

Senior Regulatory Affairs Associate (MAA)

Senior Manager, IT Service Operations